Issue 24 - The Cancer Letter

<img class="lazy" src="data:image/svg+xml,%3Csvg%20xmlns='http://www.w3.org/2000/svg'%20viewBox='0%200%201%201'%3E%3C/svg%3E" data-src="https://cdn.cancerletter.com/media/2021/03/17053004/TCL-logo-horizontal-white.png" alt="" >

Vol.

18

No.

24

June 12, 1992Jun 12, 1992

Free

DOWNLOAD THE PDF

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

In Brief: Seffrin’s ACS Appointment Is Official; Liotta Selected As NIH; Strategic Plan Meetings

Other ASCO Plenary Papers: Long Awaited Chemotherapy Results

Congress Okays NIH Reauthorization, Allows NCI $472 Mil. More

Gallo Inquiry Complete; NCAB’s AIDS Committee Plans Q&A Session

NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation

Recent Issues

Volume 52 | Issue 05 - February 06, 2026

Volume 52 | Issue 04 - January 30, 2026

Volume 52 | Issue 03 - January 23, 2026

Volume 52 | Issue 02 - January 16, 2026

Volume 52 | Issue 1 - January 09, 2026

Volume 51 | Issue 46 - December 19, 2025